Together with the editors, Michael Berk and colleagues, authors of “The Impact of Smoking on Clinical Outcomes After First-Episode Psychosis: Longer-Term Outcome Findings From the EPPIC 800 Follow-Up Study,” appearing in Journal of Dual Diagnosis, volume 6, numbers 3–4, pp. 212–234, wish to correct an omission in the Disclosures section:
The authors wish to disclose that Ms. Harris receives research funding from the Australian Government Department of Health and Ageing, Queensland Health, Disability Services Queensland, the Australian Rotary Health Research Fund, and AstraZeneca. Dr. McGorry receives research grant support from Janssen-Cilag and AstraZeneca. He also receives honoraria from AstraZeneca, Janssen-Cilag, Pfizer, and Eli Lilly.
The authors regret the omission.